US vs. Foreign Drug Pricing Debate Must Include Global R&D ‘Free Riding,’ Pharma CEOs Say

 
• By Cathy Kelly

Any Trump Administration policy involving international pricing should include foreign governments paying higher prices, as well as lowering US prices, CEOs say.

Ex-US countries should pay higher prices to help the US carry the global R&D load, the pharma industry argues. (Shutterstock)

More from Medicare

More from Pricing Debate